Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

REPLIGEN CORP Director's Dealing 2019

Jul 18, 2019

30826_dirs_2019-07-17_251cd02e-f174-44c5-8a75-bc2cf6680827.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2019-07-15

Reporting Person: Snodgres Jon (Chief Financial Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-07-15 Common Stock F 295 $85.95 Disposed 28239 Direct

Footnotes

F1: Payment of tax liability made via forfeiture of 295 shares of Common Stock valued at a price of $85.95 per share on July 15, 2019.